Rising antibiotic resistance to standard prophylactic regimens in the United States could have disastrous consequences for patients undergoing surgery or receiving cancer chemotherapy. Resistance is involved in up to half of infections after surgery and more than one-fourth of infections after chemotherapy (Lancet Infect Dis 2015 Oct. 15.
OSAP Disclaimer | Please notify our webmaster of any problems with this website. OSAP thanks its Super Sponsors for their support in 2016. Sponsorship does not imply endorsement by OSAP of a company's products or services.